Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ELOX
$15.13
-1.82%
ELOX
· Eloxx Pharmaceuticals, Inc.
$15.13
-0.28 (-1.82%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 5, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$62.20M
Shares
4.04M
Volume · Oct 6
61.29K
Avg daily vol (3M)
47.21K
All webcasts
Earnings call · FY2021 Q3
Eloxx Pharmaceuticals, Inc. (ELOX) Q3 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$0.11
Net income
-$9.88M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 9, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 8, 2021 · complete as-filed document